Variant report
Variant | nsv526485 |
---|---|
Chromosome Location | chr12:59412802-59422668 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:36)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:36 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr12:59422466-59422666 | A549 | lung: | n/a | chr12:59422524-59422533 chr12:59422524-59422533 chr12:59422524-59422533 chr12:59422522-59422533 chr12:59422524-59422533 chr12:59422524-59422535 |
2 | CEBPB | chr12:59420905-59421451 | MCF-7 | breast: | n/a | chr12:59421183-59421194 |
3 | CEBPB | chr12:59421021-59421369 | MCF-7 | breast: | n/a | chr12:59421183-59421194 |
4 | CEBPB | chr12:59422407-59422651 | HepG2 | liver: | n/a | chr12:59422524-59422533 chr12:59422524-59422533 chr12:59422524-59422533 chr12:59422522-59422533 chr12:59422524-59422533 chr12:59422524-59422535 |
5 | CTCF | chr12:59414340-59414490 | AG10803 | skin: | n/a | n/a |
6 | CTCF | chr12:59414340-59414490 | AG04449 | skin: | n/a | n/a |
7 | E2F4 | chr12:59413124-59413281 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | E2F4 | chr12:59417159-59417354 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | E2F4 | chr12:59419610-59419688 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | EP300 | chr12:59420891-59421500 | T-47D | breast: | n/a | n/a |
11 | ESR1 | chr12:59418488-59418914 | T-47D | breast: | n/a | chr12:59418694-59418711 |
12 | ESR1 | chr12:59418522-59418815 | T-47D | breast: | n/a | chr12:59418694-59418711 |
13 | ESR1 | chr12:59418475-59418843 | T-47D | breast: | n/a | chr12:59418694-59418711 |
14 | FOXA1 | chr12:59420987-59421379 | T-47D | breast: | n/a | n/a |
15 | FOXA1 | chr12:59420872-59421431 | T-47D | breast: | n/a | n/a |
16 | GATA3 | chr12:59414056-59414501 | T-47D | breast: | n/a | n/a |
17 | GATA3 | chr12:59420971-59421515 | MCF-7 | breast: | n/a | chr12:59421456-59421464 |
18 | GATA3 | chr12:59421114-59421345 | MCF-7 | breast: | n/a | n/a |
19 | GATA3 | chr12:59420907-59421506 | T-47D | breast: | n/a | chr12:59421456-59421464 |
20 | GATA3 | chr12:59420217-59420709 | MCF-7 | breast: | n/a | n/a |
21 | GATA3 | chr12:59420896-59421470 | T-47D | breast: | n/a | chr12:59421456-59421464 |
22 | GATA3 | chr12:59413913-59414619 | T-47D | breast: | n/a | n/a |
23 | GATA3 | chr12:59420965-59421640 | MCF-7 | breast: | n/a | chr12:59421456-59421464 |
24 | HDAC2 | chr12:59420980-59421455 | MCF-7 | breast: | n/a | n/a |
25 | JUND | chr12:59420847-59421532 | T-47D | breast: | n/a | chr12:59420849-59420861 |
26 | KAP1 | chr12:59418547-59419441 | HEK293 | kidney: | n/a | n/a |
27 | POLR2A | chr12:59422584-59422636 | GM12878 | blood: | n/a | n/a |
28 | POLR2A | chr12:59417007-59417175 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | POLR2A | chr12:59421339-59421343 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr12:59414089-59414255 | GM12878 | blood: | n/a | n/a |
31 | REST | chr12:59416265-59416648 | H1-neurons | neurons: | n/a | n/a |
32 | REST | chr12:59416106-59416650 | H1-neurons | neurons: | n/a | n/a |
33 | STAT3 | chr12:59413235-59413474 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | STAT3 | chr12:59419568-59419592 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | TBP | chr12:59417838-59417883 | Hela-S3 | cervix: | n/a | n/a |
36 | ZNF217 | chr12:59420955-59421424 | MCF-7 | breast: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-362K2.2.1-3 | chr12:59413950-59414675 | NONHSAT029040 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPS6P22 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7974440 | chr12:59412802-59412803 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs563981813 | chr12:59412814-59412815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566265734 | chr12:59412856-59412857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113666427 | chr12:59412884-59412885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536308708 | chr12:59412895-59412896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533309131 | chr12:59412896-59412897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143792879 | chr12:59412919-59412920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78119326 | chr12:59412971-59412972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577413662 | chr12:59412984-59412985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1444102 | chr12:59413022-59413023 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs151274716 | chr12:59413044-59413045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577171908 | chr12:59413109-59413110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191040686 | chr12:59413129-59413130 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs547414275 | chr12:59413133-59413134 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs140475675 | chr12:59413181-59413182 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs150406226 | chr12:59413225-59413226 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs546925315 | chr12:59413252-59413253 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs76938125 | chr12:59413260-59413261 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs535888100 | chr12:59413261-59413262 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs371633868 | chr12:59413262-59413263 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs75320985 | chr12:59413308-59413309 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs563073528 | chr12:59413341-59413342 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs574878753 | chr12:59413342-59413343 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs545361463 | chr12:59413358-59413359 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs183404714 | chr12:59413411-59413412 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs532649246 | chr12:59413427-59413428 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs186653132 | chr12:59413535-59413536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528188321 | chr12:59413539-59413540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373632260 | chr12:59413676-59413677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559681253 | chr12:59413681-59413682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192070838 | chr12:59413698-59413699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549110575 | chr12:59413725-59413726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138129323 | chr12:59413828-59413829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570196536 | chr12:59413835-59413836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74397303 | chr12:59413836-59413837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74091469 | chr12:59413838-59413839 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs570836629 | chr12:59413847-59413848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183478823 | chr12:59413855-59413856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187705504 | chr12:59413870-59413871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192586416 | chr12:59413925-59413926 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs182147067 | chr12:59413933-59413934 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs199907266 | chr12:59413963-59413964 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs79953325 | chr12:59413966-59413967 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs574966753 | chr12:59413984-59413985 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs74091470 | chr12:59413992-59413993 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs550855977 | chr12:59414032-59414033 | Weak transcription Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs537628974 | chr12:59414041-59414042 | Weak transcription Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs551164479 | chr12:59414046-59414047 | Weak transcription Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs557289481 | chr12:59414047-59414048 | Weak transcription Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs17121854 | chr12:59414066-59414067 | Weak transcription Active TSS | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:59408600-59420800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr12:59414000-59414800 | Active TSS | NHDF-Ad | bronchial |
3 | chr12:59416000-59418800 | Weak transcription | Aorta | Aorta |
4 | chr12:59417000-59417400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr12:59417200-59418800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr12:59417400-59417800 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr12:59417400-59418200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr12:59417400-59418200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr12:59417400-59418200 | Enhancers | Osteobl | bone |
10 | chr12:59417400-59418600 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr12:59417400-59419200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
12 | chr12:59417600-59430200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr12:59417800-59418400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr12:59419200-59426400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
15 | chr12:59419800-59420000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr12:59420000-59420200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr12:59420600-59421400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr12:59421400-59425200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |